Increased amyloidogenesis by MEK or HSF1 inhibition blunted melanoma growth, by exacerbating proteotoxic stress to a lethal threshold, thus suggesting that the induction of proteotoxic stress might have relevant anti-melanoma effects and represent a promising therapeutic strategy (110). The gene discussed is MAP2K7; the disease is melanoma.